LogicBio Therapeutics Inc
NASDAQ:LOGC
Balance Sheet
Balance Sheet Decomposition
LogicBio Therapeutics Inc
Current Assets | 32.8m |
Cash & Short-Term Investments | 30.8m |
Other Current Assets | 2m |
Non-Current Assets | 5.8m |
PP&E | 5.2m |
Other Non-Current Assets | 622k |
Current Liabilities | 16.4m |
Accounts Payable | 1.1m |
Accrued Liabilities | 3.7m |
Other Current Liabilities | 11.7m |
Non-Current Liabilities | 6.4m |
Long-Term Debt | 2.6m |
Other Non-Current Liabilities | 3.8m |
Balance Sheet
LogicBio Therapeutics Inc
Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
2
|
25
|
81
|
33
|
70
|
53
|
|
Cash Equivalents |
2
|
25
|
81
|
33
|
70
|
53
|
|
Short-Term Investments |
0
|
0
|
0
|
18
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
1
|
1
|
2
|
2
|
2
|
|
Total Current Assets |
2
|
26
|
82
|
53
|
73
|
56
|
|
PP&E Net |
0
|
0
|
1
|
2
|
7
|
6
|
|
PP&E Gross |
0
|
0
|
1
|
2
|
7
|
6
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
|
Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
Total Assets |
2
N/A
|
26
+1 189%
|
83
+217%
|
56
-33%
|
81
+45%
|
63
-22%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
1
|
1
|
1
|
0
|
1
|
|
Accrued Liabilities |
1
|
1
|
2
|
3
|
4
|
5
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
3
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
11
|
|
Total Current Liabilities |
1
|
2
|
3
|
4
|
6
|
20
|
|
Long-Term Debt |
0
|
0
|
0
|
10
|
8
|
5
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
5
|
7
|
|
Total Liabilities |
1
N/A
|
2
+86%
|
3
+57%
|
13
+397%
|
19
+44%
|
32
+67%
|
|
Equity | |||||||
Common Stock |
4
|
33
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
4
|
10
|
27
|
67
|
100
|
140
|
|
Additional Paid In Capital |
1
|
1
|
107
|
110
|
161
|
171
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
1
N/A
|
24
+2 104%
|
80
+228%
|
42
-47%
|
61
+45%
|
31
-50%
|
|
Total Liabilities & Equity |
2
N/A
|
26
+1 189%
|
83
+217%
|
56
-33%
|
81
+45%
|
63
-22%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
21
|
21
|
22
|
23
|
32
|
33
|